Author

Pablo Clavero

Consorci Institut D'Investigacions Biomediques August Pi I Sunyer

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Organism:mouse· 2 Assay:ATAC-seq· 1 Assay:bulk RNA-seq· 1 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

Marta Giménez-AlejandreiD· 2 shared Sònia GuedaniD· 2 shared Alba Rodríguez-GarcíaiD· 1 shared Aleix PratiD· 1 shared Alexandra Arias· 1 shared Almudena Neva-AlejoiD· 1 shared Álvaro Urbano-IspizúaiD· 1 shared Anna Esteve‐CodinaiD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Marta Giménez-AlejandreORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

C1q from C1q+ tumor-associated myeloid cells promotes resistance to T-cell engagers and CAR T-cells and is induced by LIF and glucocorticoids

María López Vázquez, Sergio Espinosa-Gil, Raffaella Iurlaro, Laura Carrillo Bosch, Ariadna Grinyo i Escuer, Dario Solis Sayago, Alexandra Arias, Isabel Cuartas, Almudena Neva-Alejo, Laia Cuesta‐Casanovas, Ester Bonfill‐Teixidor, Cayetano Galera Martinez, Cesar Merino Allona, Maria Duarte Leon, Irepan Salvador‐Martínez, , Joan Seoane

This study identifies C1q from C1q+ tumor-associated myeloid cells as a key immunosuppressive factor in glioblastoma that impairs T-cell engagers and CAR T-cell efficacy, induced by LIF and glucocorticoids.

bioRxiv · Sep 17, 2026 · PreprintCancer Biology

In vivo CRISPR-based screen identifies ZC3H12C as a mediator of CAR-T cell dysfunction in solid tumors

Paula Barbao, Alba Rodríguez-García, Ariel Galindo‐Albarrán, Marta Giménez-Alejandre, Pablo Clavero, Teresa Lobo‐Jarne, Marta Botas, Guillem Colell, Joan Castellsagué, Guim Cascalló, Irene Andreu-Saumell, Marta Soria-Castellano, Salut Colell, Berta Marzal, Beatriz Martín-Mur, , Sònia Guedan

The paper identifies ZC3H12C as a mediator of CAR-T cell dysfunction in solid tumors through an in vivo CRISPR screen and validates its role using single-cell RNA and ATAC-seq.

bioRxiv · May 2, 2026 · PreprintImmunology